To further clarify that NLRP12 promotes gastric cancer proliferation through HK2-mediated glycolysis, we employed both pharmacological inhibition (2-DG, a competitive HK2 inhibitor) and genetic silencing (shRNA-mediated HK2 knockdown). The gene discussed is HK2; the disease is gastric cancer.